SCHEMBL29495930

SCHEMBL29495930

CC(=O)c1cccc(S(F)(F)(F)(F)F)c1

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ AKR1C3 P42330 3/20 0.51
▸ AKR1C2 P52895 3/20 0.51
▸ ALDH1A1 P00352 5/20 0.46
▸ KMT2A Q03164 5/20 0.44
▸ MEN1 O00255 4/20 0.44
▸ SMN1; SMN2 Q16637 2/20 0.44
▸ MAPK1 P28482 2/20 0.44
▸ NPSR1 Q6W5P4 1/20 0.44
▸ TDP1 Q9NUW8 1/20 0.43
▸ NPC1 O15118 2/20 0.41
▸ RAB9A P51151 2/20 0.41
▸ L3MBTL1 Q9Y468 1/20 0.41
▸ GAA P10253 1/20 0.41
▸ PTGS1 P23219 1/20 0.41
▸ PTGS2 P35354 1/20 0.41
▸ TAS2R14 Q9NYV8 1/20 0.41
▸ MAOB P27338 1/20 0.41
▸ HTT P42858 1/20 0.40
▸ CREBBP Q92793 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1195462 1.00 AKR1C3 (0.51) AKR1C3AKR1C2ALDH1A1KMT2AMEN1
SCHEMBL1169066 0.82 AKR1C3 (0.72) AKR1C3AKR1C2PTGS1PTGS2TAS2R14
SCHEMBL22628424 0.80 AKR1C3 (0.44) AKR1C3AKR1C2NPC1RAB9APTGS1
SCHEMBL477610 0.80 AKR1C3 (0.51) AKR1C3AKR1C2ALDH1A1TDP1L3MBTL1
SCHEMBL28967024 0.79 AKR1C3 (0.47) AKR1C3AKR1C2ALDH1A1KMT2AMEN1
SCHEMBL20560610 0.78 AKR1C3 (0.50) AKR1C3AKR1C2KMT2ASMN1; SMN2NPC1
SCHEMBL279656 0.78 ALDH1A1 (0.59) ALDH1A1KMT2AMEN1SMN1; SMN2MAPK1
SCHEMBL1194372 0.76 GSK3B (0.52) AKR1C3AKR1C2PTGS1PTGS2TAS2R14
SCHEMBL1633802 0.76 ALDH1A1 (0.58) AKR1C3AKR1C2ALDH1A1KMT2AMEN1
SCHEMBL30782680 0.76 ALDH1A1 (0.58) AKR1C3AKR1C2ALDH1A1KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117534667-A Crystal forms of pyridopyrimidinone compound, acid salts thereof, crystal forms of acid salts thereof and use 武汉人福创新药物研发中心有限公司 2024-02-09 — — CN disclosed
CN-117357650-A Pharmaceutical composition comprising SOS1 inhibitor 武汉人福创新药物研发中心有限公司 2024-01-09 — — CN disclosed
CN-114907341-A Pyridopyrimidinone derivatives, and preparation method and application thereof 武汉人福创新药物研发中心有限公司 2022-08-16 — — CN disclosed
CN-114716478-A 6-substituted phosphoryl quinazoline derivative and preparation method and application thereof 武汉人福创新药物研发中心有限公司 2022-07-08 — — CN disclosed
Send feedback